VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 101 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 17.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $60,776 | -64.5% | 7,842 | -47.6% | 0.00% | – |
| Q2 2023 | $171,315 | +975.4% | 14,962 | +624.2% | 0.00% | – |
| Q1 2023 | $15,930 | +26.6% | 2,066 | +0.1% | 0.00% | – |
| Q4 2022 | $12,585 | -3.2% | 2,063 | -11.2% | 0.00% | – |
| Q3 2022 | $13,000 | -55.2% | 2,324 | -52.7% | 0.00% | – |
| Q2 2022 | $29,000 | -31.0% | 4,915 | -12.2% | 0.00% | – |
| Q1 2022 | $42,000 | -53.8% | 5,598 | -83.3% | 0.00% | – |
| Q4 2021 | $91,000 | -38.5% | 33,584 | -40.5% | 0.00% | – |
| Q3 2021 | $148,000 | -64.3% | 56,483 | -43.7% | 0.00% | – |
| Q2 2021 | $414,000 | +12.2% | 100,243 | +27.9% | 0.00% | – |
| Q1 2021 | $369,000 | -63.3% | 78,356 | -44.3% | 0.00% | – |
| Q4 2020 | $1,006,000 | -78.3% | 140,717 | -67.5% | 0.00% | -100.0% |
| Q3 2020 | $4,626,000 | -21.0% | 433,564 | -6.6% | 0.00% | -50.0% |
| Q2 2020 | $5,856,000 | +39.7% | 464,029 | +1.3% | 0.00% | +100.0% |
| Q1 2020 | $4,191,000 | -22.7% | 457,906 | +17.8% | 0.00% | 0.0% |
| Q4 2019 | $5,421,000 | -12.4% | 388,571 | +8.1% | 0.00% | -50.0% |
| Q3 2019 | $6,185,000 | -33.1% | 359,393 | +5.8% | 0.00% | -33.3% |
| Q2 2019 | $9,250,000 | +33.5% | 339,799 | -6.1% | 0.00% | +50.0% |
| Q1 2019 | $6,927,000 | +83.8% | 361,933 | -9.7% | 0.00% | +100.0% |
| Q4 2018 | $3,768,000 | -62.7% | 400,859 | -24.9% | 0.00% | -66.7% |
| Q3 2018 | $10,105,000 | +14.8% | 534,087 | +18.6% | 0.00% | 0.0% |
| Q2 2018 | $8,802,000 | +19.8% | 450,480 | +15.2% | 0.00% | +50.0% |
| Q1 2018 | $7,347,000 | -1.5% | 390,983 | -13.0% | 0.00% | 0.0% |
| Q4 2017 | $7,462,000 | -3.9% | 449,525 | +19.2% | 0.00% | 0.0% |
| Q3 2017 | $7,766,000 | +848.2% | 377,190 | +312.8% | 0.00% | – |
| Q2 2017 | $819,000 | -26.0% | 91,384 | +9.3% | 0.00% | – |
| Q1 2017 | $1,107,000 | +123.2% | 83,577 | +114.4% | 0.00% | – |
| Q4 2016 | $496,000 | +60.5% | 38,978 | +51.7% | 0.00% | – |
| Q3 2016 | $309,000 | +55.3% | 25,695 | +41.5% | 0.00% | – |
| Q2 2016 | $199,000 | +1321.4% | 18,156 | +996.4% | 0.00% | – |
| Q1 2016 | $14,000 | -85.6% | 1,656 | -62.7% | 0.00% | – |
| Q4 2015 | $97,000 | – | 4,440 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |